Total adjustments Sample Clauses

Total adjustments. Net cash used in operating 1,892,866 ------------- 16,435,596 ------------- 79,797 ------------ 11,528,789 ------------ 104,153 ------------ 3,266,293 ------------ activities........................ Investing activities (36,001,528) ------------- (29,951,874) ------------ (21,705,618) ------------ Purchases of securities available- for-sale.......................... (148,414,555) (29,561,916) (63,891,102) Proceeds from sales of securities available-for-sale................ 2,513,437 11,111,339 26,025,226 Proceeds from maturities of securities available-for-sale..... 33,723,000 41,915,000 56,622,884 Purchases of property and equipment......................... (953,242) (558,163) (2,801,332) PolaRx acquisition, net of cash acquired.......................... Net cash provided by (used in) (781,438) ------------- -- ------------ -- ------------
Total adjustments. Net cash provided by (used in) operating (3,714) -------- 26,652 -------- (6,676) -------- 12,190 -------- (10,169) -------- 21,266 -------- Cash flows from investing activities: 19 435 55 -- -- 1,673 -- 5,965 -- 33,948 55,384 44,370 -- -- 1,259 -------- -------- -------- Proceeds from disposition of assets, net........... Proceeds from production payment receivables....... Purchase of short-term investments................. Purchase of long-term investments.................. Proceeds from sale of long-term investments........ Proceeds of maturities of short-term investments... Refund of revolver from non-investment grade security.........................................
Total adjustments. ESTIMATED FEDERAL SHARE OF EXPENDITURES FOR QUARTER BEGINNING 10/01/2019 - 09/30/2020 3. NET AMOUNT TO BE CERTIFIED................ TOTAL AMOUNT TO BE CERTIFIED............................................................... $ B. 6,873,173,005 DATE APPROVED COMPUTATION PREPARED BY : INTERNAL TRANSMITTAL NO. COMPUTATION REVIEWED BY : FORM CMS-152 (10/14/93) PART A PAGE 2 OF 3 DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES STATE QUARTER/FISCAL YEAR: SECOND/2020 THIS AWARD IS FUNDED UNDER HHS SINGLE LETTER OF CREDIT NO. 75-08 CENTRAL REGISTRY SYSTEM 191-089-6842-A1 (OLD) PROGRAM FUNDS COMMON AMOUNT MAP/ADM IDENTIFICATION ACCOUNTING DOCUMENT SUBACCOUNT NUMBER NUMBER NUMBER XIX-MAP20 75X0512 05993275 2005WA5MAP 6,581,299,000 XIX-ADM20 75X0512 05993274 2005WA5ADM 291,874,005 ENTITY IDENTIFICATION NUMBER (CRS/EIN) 191-141-2780-A1 (NEW) * * TOTAL AMOUNT TO BE CERTIFIED 6,873,173,005 * CURRENT QUARTER FUNDING PAGE 3 of 3 CENTERS FOR MEDICARE & MEDICAID SERVICES FOOTNOTES STATE: WASHINGTON QUARTER/FISCAL YEAR: SECOND/2020 A. See Attachment 1.
Total adjustments. (61,958) ------------ (632,848) ------------ (96,391) ----------- 1,449,912 ----------- 3,003,339 ------------- 10,734,439 ------------- terest............................. $ 205,903 $ 261,508 $ 1,831,928 ============ =========== =============
Total adjustments. Net cash used in 1,646,935 ------------ (283,589) ------------ 1,652,873 ------------ 2,585,890 ------------ (245,376) ------------ 3,010,279 ------------ 4,712,232 ------------ 11,083,698 ------------ operating activities:.. INVESTING ACTIVITIES (23,309,883) ------------ (11,342,299) ------------ (16,982,196) ------------ (86,014,423) ------------ Purchases of securities available- for-sale.............. (85,765,759) (27,113,929) (13,165,743) (161,791,786) Proceeds from sales of securities available- for-sale.............. 1,999,444 -- 3,856,167 16,889,757 Proceeds from maturities of securities available- for-sale.............. 47,845,281 16,439,000 1,059,296 82,945,068 Purchase of property and equipment......... (2,540,798) (1,046,640) (204,424) (13,875,734) Dispositions of property and equipment............. 15,831 -- 36,476 167,300 Net cash used in ------------ ------------ ------------ ------------ investing activities... (38,446,001) ------------ (11,721,569) ------------ (8,418,228) ------------ (75,665,395) ------------ FINANCING ACTIVITIES Sales of common stock to founders............... -- -- -- 80,000 Proceeds from borrowings from shareholders...... -- -- -- 850,000 Sale of common stock via initial public offering, net of offering costs......... 26,802,250 -- -- 26,802,250 Sale of common stock via follow-on public offering, net of offering costs......... 34,262,000 -- -- 34,262,000 Sale of Series A Preferred Stock via private placement, net of offering costs...... -- 16,870,000 30,496,204 47,366,204 Sale of Series B Preferred Stock via private placement, net
Total adjustments. [Lines 7a and 7b] -----------